Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats

Myocardial ischemia-reperfusion (IR) injury contributes to adverse cardiac outcomes after myocardial ischemia, cardiac surgery, or circulatory arrest. In this study, we evaluated the ability of combined SS31-mitochondria (Mito) therapy to protect heart cells from myocardial IR injury. Adult male SD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Fan-Yen, Shao, Pei-Lin, Wallace, Christopher Glenn, Chua, Sarah, Sung, Pei-Hsun, Ko, Sheung-Fat, Chai, Han-Tan, Chung, Sheng-Ying, Chen, Kuan-Hung, Lu, Hung-I, Chen, Yi-Ling, Huang, Tien-Hung, Sheu, Jiunn-Jye, Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164143/
https://www.ncbi.nlm.nih.gov/pubmed/30223594
http://dx.doi.org/10.3390/ijms19092782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164143/
https://www.ncbi.nlm.nih.gov/pubmed/30223594
http://dx.doi.org/10.3390/ijms19092782

Ejemplares similares